In terms of Regulation 30 of SEBI (Listing Obligation Disclosure Requirement) Regulations, 2015 and in addition to disclosure regarding appointment of Director dated January 22nd 2025, we wish to inform that the Board considered and approved Reconstitution of the Committees
Reconstitution Of Committees Of The Board
Filed with BSE · · 2 pages · English
Release
Earlier from Supha Pharmachem
- Announcement under Regulation 30 (LODR)-Change in Directorate
- Board Meeting Outcome for Outcome Of Board Meeting Held On Wednesday, January 22, 2025.
- Supha Pharmachem Ltd Press Release Jan 17 2025
- Board Meeting Intimation for Pursuant To Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
- Supha Pharmachem Ltd Press Release Jan 10 2025
Later from Supha Pharmachem
- Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
- Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
- Supha Pharmachem Ltd Press Release Jan 24 2025
- Board Meeting Outcome for Outcome Of Board Meeting Held On Friday, February 14, 2025.
- Results For The Quarter And Nine Months Ended December 31, 2024.
Follow Supha Pharmachem into a list and get an email when it puts out news.
Follow Supha Pharmachem